rs144891494
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_001287135.2(CDK14):c.183C>T(p.Pro61Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000635 in 1,613,674 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0035 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00033 ( 3 hom. )
Consequence
CDK14
NM_001287135.2 synonymous
NM_001287135.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.58
Publications
0 publications found
Genes affected
CDK14 (HGNC:8883): (cyclin dependent kinase 14) Enables cyclin binding activity and cyclin-dependent protein serine/threonine kinase activity. Involved in G2/M transition of mitotic cell cycle and regulation of canonical Wnt signaling pathway. Located in cytosol; nucleoplasm; and plasma membrane. Part of cytoplasmic cyclin-dependent protein kinase holoenzyme complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 7-90726626-C-T is Benign according to our data. Variant chr7-90726626-C-T is described in ClinVar as [Benign]. Clinvar id is 722842.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 535 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK14 | NM_001287135.2 | c.183C>T | p.Pro61Pro | synonymous_variant | Exon 3 of 15 | ENST00000380050.8 | NP_001274064.1 | |
CDK14 | NM_012395.3 | c.129C>T | p.Pro43Pro | synonymous_variant | Exon 2 of 14 | NP_036527.1 | ||
CDK14 | NM_001287136.1 | c.45C>T | p.Pro15Pro | synonymous_variant | Exon 2 of 14 | NP_001274065.1 | ||
CDK14 | NM_001287137.1 | c.-110C>T | 5_prime_UTR_variant | Exon 2 of 13 | NP_001274066.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00348 AC: 529AN: 152072Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
529
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000833 AC: 209AN: 250876 AF XY: 0.000583 show subpopulations
GnomAD2 exomes
AF:
AC:
209
AN:
250876
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000335 AC: 489AN: 1461484Hom.: 3 Cov.: 31 AF XY: 0.000293 AC XY: 213AN XY: 727036 show subpopulations
GnomAD4 exome
AF:
AC:
489
AN:
1461484
Hom.:
Cov.:
31
AF XY:
AC XY:
213
AN XY:
727036
show subpopulations
African (AFR)
AF:
AC:
407
AN:
33460
American (AMR)
AF:
AC:
21
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26128
East Asian (EAS)
AF:
AC:
0
AN:
39690
South Asian (SAS)
AF:
AC:
2
AN:
86252
European-Finnish (FIN)
AF:
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
6
AN:
1111746
Other (OTH)
AF:
AC:
51
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00352 AC: 535AN: 152190Hom.: 5 Cov.: 32 AF XY: 0.00335 AC XY: 249AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
535
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
249
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
508
AN:
41524
American (AMR)
AF:
AC:
22
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
67998
Other (OTH)
AF:
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jan 30, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.